Raxtozinameran
ATC J07BN01 · 3 markets · 12 records
Raxtozinameran
Forms
AU 9 records · 8 strengths
- 0.016 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 10 micrograms/0.3 mL suspension for injection single dose vialCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection multidose vial
- 0.225 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial
- 0.13 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection multidose vial
- 0.074 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 10 micrograms/0.3 mL suspension for injection multidose vial
- 0.048 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection sinigle dose vial
- 0.043 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection prefilled plastic syringe
- 0.042 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection prefilled glass syringe
- 0.04 mginjectionCOMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection multidose vial
HK 1 records · 1 strengths
Records without a stated strength · 1 COMIRNATY OMICRON XBB.1.5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) 30 MICROGRAMS/DOSE
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.